Alexander KarpAlexander Karp earned $1B in 2024

In 2023, Marino Garcia earned $496.02K in total compensation at Dianthus Therapeutics, including $174.86K salary and $321.16K bonus. 2+ years at the helm of Dianthus Therapeutics.

Compensation History

Annual executive compensation data for Marino Garcia, including salary, bonuses, and stock awards.

Year

2023

Total Compensation

$496.02K

Salary

$174.86K

Bonus

$321.16K

Other

$0.00

Salary

$174.86K

Board Justification

The compensation philosophy focuses on aligning executive compensation with company performance, peer benchmarking, and retention strategies, aiming to motivate executives to achieve short- and long-term results in the best interests of stockholders.

Bonus

$321.16K

Board Justification

The bonus is based on the annual cash incentive payouts earned for performance in 2023, which are expected to be paid in February 2024. The annual incentive program was based on achievement of corporate performance goals related to clinical trial readiness and pipeline development, with payouts approved at 115% of target.

Other Compensation

$0.00

Board Justification

No other compensation was reported for 2023.

Restricted Stock

$0.000 common stock

Board Justification

No stock was reported as vested in 2023.

Performance Metrics

The performance metrics for determining compensation in 2023 included execution towards organizational readiness for clinical trials and pipeline development.

D

Marino Garcia

CEO of Dianthus Therapeutics

Education

M.B.A. from the Ivey Business School at Western University and Bachelor of Commerce from Concordia University

Field of Expertise

Business & Management - Business Development

Sector of Economy

Healthcare

Born

January 1, 1966 - 59 years ago

CEO of Dianthus Therapeutics for

2 years 2 months (Sep 2023 - Present)

Previous Experience

Senior Vice President, Corporate and Business Development at Zealand Pharma A/S

Holdings

Track Marino Garcia's stock holdings and portfolio value over time.

Insider Trading

Marino Garcia's recent stock transactions, purchases, and sales filed with the SEC.

No insider trades found for this CEO.

Rivals

Compare Marino Garcia with competitor CEOs and industry peers.